Vimarsana
Biggest News Aggregation in the World

Oliver Zerbe News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oliver Zerbe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oliver Zerbe Today - Breaking & Trending Today

Spexis provides business update and announces financial - Vimarsana News

Spexis provides business update and announces financial

Spexis provides business update and announces financial results for the first half of 2023...

Spexis provides business update and announces financial results for the first half of 2023 - adhoc - Börsennachrichten - Vimarsana News

Spexis provides business update and announces financial results for the first half of 2023 - adhoc - Börsennachrichten

Spexis AG Key word Half Year Results Spexis provides business update and announces financial results for the first half of 2023 29Sep2023 0725 CETCEST Release of an ad hoc announcement pursuant to Ar

Peptide modified to fight resistant bacteria - Vimarsana News

Peptide modified to fight resistant bacteria

Researchers have modified the chemical structure of naturally occurring peptides to develop antimicrobial molecules that bind to novel targets in resistant bacteria's metabolism.

Spexis announces the publication of promising results for a novel class of macrocyclic, peptidomimetic antibiotics in Science Advances - Vimarsana News

Spexis announces the publication of promising results for a novel class of macrocyclic, peptidomimetic antibiotics in Science Advances

Spexis AG / Key word: Scientific publication Spexis announces the publication of promising results for a novel class of macrocyclic, peptidomimetic antibiotics in Science Advances... | June 7, 2023

New class of antibiotics to fight resistant bacteria - Vimarsana News

New class of antibiotics to fight resistant bacteria

Health professionals are in urgent need of new antibiotics to tackle resistant bacteria. Researchers have now modified the chemical structure of naturally occurring peptides to develop antimicrobial molecules that bind to novel targets in the bacteria's metabolism.